Pub. Date : 2016 May
PMID : 27113739
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers. | Paclitaxel | BRCA1 DNA repair associated | Homo sapiens |
2 | The purpose of this study was to assess pathological complete response and whether it serves a surrogate for survival among patients receiving neo-adjuvant doxorubicin-cyclophosphamide followed by paclitaxel for triple-negative breast cancer with respect to BRCA1 mutation status. | Paclitaxel | BRCA1 DNA repair associated | Homo sapiens |